Chlorpheniramine maleate, phenylephrine

FDA Drug Profile — Stonarhini

Chlorpheniramine maleate, phenylephrine is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Stonarhini. Available dosage form: tablet.

Drug details

Generic Name
Chlorpheniramine maleate, phenylephrine
Brand Names
Stonarhini
Application Number
M012
Sponsor
Sato Pharmaceutical Co., Ltd.
NDC Codes
2
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE

Indications and Usage

Uses Temporarily relieves these symptoms due to common cold, hay fever or other upper respiratory allergies (allergic rhinitis). ■ sneezing ■ runny nose ■ itchy, watery eyes ■ nasal congestion, stuffy nose ■ itchy throat

Warnings

Warnings ​ Enter section text here Do not use this product ■ if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease) or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription contains an MAOI, ask a doctor or pharmacist before taking this priduct. Ask a doctor before use if you have ■ a breathing problem such as emphysema or chronic bronchitis ■ glaucoma ■ heart disease ■ thyroid disease ■ diabetes ■ high blood pressure ■difficulty in urination due to enlargement of the prostate Ask a doctor or pharmacist before use ■ if you are taking sedatives or tranquilizers When using this product ■ do not exceed recommended dosage. If nervousness, dizziness, or sleeplessness occur, discontinue use and consult a doctor. ■ you may get drowsy. ■ may cause excitability, especially in children. ■ alcohol, sedatives and tranquilizers may increase the drowsiness effect. ■ avoid alcoholic beverages. ■ use caution when driving a motor vehicle or operating machinery. Stop use and ask a doctor if ■ symptoms do not improve within seven days ■ symptoms are accompanied by fever

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.